Healthcare provider profile · identity verified

Nicholas Sean Packey, D.O.

Family Practice · GARDEN CITY, MI · NPI 1104130558

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	534	161
Losartan Potassium	Losartan Potassium	267	80
Levothyroxine Sodium	Levothyroxine Sodium	264	68
Metformin Hcl	Metformin Hcl	211	62
Amlodipine Besylate	Amlodipine Besylate	206	57
Lisinopril	Lisinopril	200	63
Metoprolol Succinate	Metoprolol Succinate	195	60
Omeprazole	Omeprazole	195	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	194	30
Metoprolol Tartrate	Metoprolol Tartrate	137	40
Albuterol Sulfate Hfa	Albuterol Sulfate	133	39
Hydrochlorothiazide	Hydrochlorothiazide	133	38
Nifedipine Er	Nifedipine	130	34
Alprazolam	Alprazolam	127	22
Gabapentin	Gabapentin	122	31
Simvastatin	Simvastatin	115	31
Furosemide	Furosemide	103	41
Tamsulosin Hcl	Tamsulosin Hcl	100	28
Januvia	Sitagliptin Phosphate	97	25
Pantoprazole Sodium	Pantoprazole Sodium	90	29
Zolpidem Tartrate	Zolpidem Tartrate	81	15
Sertraline Hcl	Sertraline Hcl	76	26
Potassium Chloride	Potassium Chloride	71	24
Ezetimibe	Ezetimibe	70	17
Ventolin Hfa	Albuterol Sulfate	67	17
Eliquis	Apixaban	63	20
Hydralazine Hcl	Hydralazine Hcl	62	16
Rosuvastatin Calcium	Rosuvastatin Calcium	60	19
Allopurinol	Allopurinol	55	16
Fluticasone Propionate	Fluticasone Propionate	51	26
Clonidine Hcl	Clonidine Hcl	49	suppressed
Tramadol Hcl	Tramadol Hcl	49	12
Clonazepam	Clonazepam	47	suppressed
Glipizide	Glipizide	47	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	46	11
Ibuprofen	Ibuprofen	46	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	46	suppressed
Jardiance	Empagliflozin	45	11
Trazodone Hcl	Trazodone Hcl	44	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	suppressed
Carvedilol	Carvedilol	39	14
Atenolol	Atenolol	36	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Spironolactone	Spironolactone	36	13
Pravastatin Sodium	Pravastatin Sodium	35	suppressed
Novolog Flexpen	Insulin Aspart	33	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	suppressed
Finasteride	Finasteride	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Ozempic	Semaglutide	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Meclizine Hcl	Meclizine Hcl	29	suppressed
Tradjenta	Linagliptin	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Gemfibrozil	Gemfibrozil	28	suppressed
Glimepiride	Glimepiride	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Famotidine	Famotidine	27	14
Fluoxetine Hcl	Fluoxetine Hcl	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Mounjaro	Tirzepatide	23	suppressed
Torsemide	Torsemide	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	22	suppressed
Azithromycin	Azithromycin	21	19
Montelukast Sodium	Montelukast Sodium	21	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	20	suppressed
Metformin Hcl Er	Metformin Hcl	20	suppressed
Methylprednisolone	Methylprednisolone	20	19
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	12
Enalapril Maleate	Enalapril Maleate	18	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Benztropine Mesylate	Benztropine Mesylate	16	suppressed
Haloperidol	Haloperidol	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Cephalexin	Cephalexin	15	13
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	13
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	13	suppressed
Diltiazem Hcl	Diltiazem Hcl	13	suppressed
Hydrocortisone Valerate	Hydrocortisone Valerate	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Belsomra	Suvorexant	12	suppressed
Easy Touch Pen Needle	Pen Needle, Diabetic	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Risperidone	Risperidone	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	12	suppressed
Armodafinil	Armodafinil	11	suppressed
Brilinta	Ticagrelor	11	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Glyburide	Glyburide	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error